PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD,…
Recalling firm: Beta Labs
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Dec 3, 2014.
Check your package
Compare the exact product and package details with the label you have.
029882559802FDA code information
Lot # 1205129, Exp 12/16
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 029882559802 | L GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802 |
| lot | 1205129 | Lot # 1205129, Exp 12/16 |
Original FDA recall reason
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Recall details
- Recall number
- F-2400-2014
- Event ID
- 65585
- FDA status
- Terminated
- Initiated
- Jun 20, 2013
- Reported
- Sep 3, 2014
- Classified
- Aug 27, 2014
- Terminated
- Dec 3, 2014
- Quantity
- 743 units
- Location
- Memphis, TN, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Press Release
Where it was distributed
nationwide and UK
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.